Evidence map›Paper›PMID 31414189›Full record

ArticleHerz2021

Effect of new oral anticoagulants on platelet indices in non-valvular atrial fibrillation patients.

Irfan Veysel Duzen, Elif Oguz, Yusuf Cekici, Fethi Yavuz, Ertan Vuruskan, Isa Sincer, Fatih Poyraz, Hayri Alıcı, Umit Yuksek, Abdullah Orhan Demirtas and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Herz, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Irfan Veysel DuzenFaculty of Medicine, Department of Cardiology, Gaziantep University, 27310, Gaziantep, Turkey. vduzen79@yahoo.com.tr.
Elif OguzFaculty of Medicine, Department of Pharmacology, Medeniyet University, Istanbul, Turkey.
Yusuf CekiciDepartment of Cardiology, Sanlıurfa Mehmet Akif Inan Research and Training Hospital, Sanlıurfa, Turkey.
Fethi YavuzDepartment of Cardiology, Adana City Education and Research Hospital, Adana, Turkey.
Ertan VuruskanFaculty of Medicine, Department of Cardiology, Gaziantep University, 27310, Gaziantep, Turkey.
Isa SincerFaculty of Medicine, Department of Cardiology, Abant Izzet Baysal University, Bolu, Turkey.
Fatih PoyrazDepartment of Cardiology, Gaziantep Defa Life Hospital, Gaziantep, Turkey.
Hayri AlıcıDepartment of Cardiology, Gaziantep Hatem Hospital, Gaziantep, Turkey.
Umit YuksekFaculty of Medicine, Department of Cardiology, Yakın Dogu University, Nicosia, Cyprus.
Abdullah Orhan DemirtasDepartment of Cardiology, Adana City Education and Research Hospital, Adana, Turkey.
Murat SucuFaculty of Medicine, Department of Cardiology, Gaziantep University, 27310, Gaziantep, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

New-generation oral anticoagulants (NOACs) are now preferred as a first-line treatment in the management of atrial fibrillation for prevention of thromboembolic complications. Mean platelet volume (MPV), one of the indicators of increased platelet activity, is also associated with an increased stroke risk in atrial fibrillation patients. The aim of this study was to evaluate changes in MPV, platelet distribution width (PDW) and plateletcrit following use of NOACs. The study included 116 patients with non-valvular atrial fibrillation without previous NOAC use. Complete blood counts, biochemical analyses and echocardiography were performed for all patients. No significant differences were observed in MPV or other platelet indices at 6 months compared to baseline. Our results indicate that MPV and other platelet indices are not affected by NOAC use in non-valvular atrial fibrillation patients.

Indexed as

Atrial FibrillationStrokeThromboembolismAdministration, OralAnticoagulantsHumansAnticoagulantsArrhythmiasEchocardiographyINRRisk factorsStroke

Identifiers

PMID31414189

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.